MedPath
Found 1 clinical trials|View Analysis
Sort by:

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

Phase 1
Recruiting
Conditions
ALL, Childhood
MDS
AML, Childhood
Hematologic Malignancy
Lymphoma
Interventions
Drug: Fludarabine
Drug: Cyclophosphamide
Drug: CD70-CAR T cell infusion (Autologous)
Drug: Mesna
First Posted Date
2024-03-22
Last Posted Date
2024-12-17
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
24
Registration Number
NCT06326463
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath